ETON PHARMACEUTICALS INC (ETON) Stock Analyst Earnings Estimates
NASDAQ:ETON - Nasdaq - US29772L1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.83M 54,475.00% | 21.25M -2.66% | 31.642M 48.90% | 38.689M 22.27% | 69.646M 80.01% | 100.84M 44.79% | 134.51M 33.39% | 237.47M 76.54% | 273.04M 14.98% | 311.05M 13.92% | 479.66M 54.21% | 527.6M 9.99% | |
| EBITDA YoY % growth | -1.04M 96.07% | -6.98M -571.15% | -291K 95.83% | -1.53M -425.77% | 18.156M 1,286.67% | 34.272M 88.76% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.5M 94.47% | -8.75M -483.33% | -1.192M 86.38% | -3.233M -171.23% | 11.475M 454.93% | 37.609M 227.75% | 41.052M 9.15% | 93.546M 127.87% | 119.26M 27.49% | 141.77M 18.87% | 262.59M 85.22% | 289.83M 10.37% | |
| Operating Margin | -6.87% | -41.18% | -3.77% | -8.36% | 16.48% | 37.30% | 30.52% | 39.39% | 43.68% | 45.58% | 54.75% | 54.93% | |
| EPS YoY % growth | -0.11 91.91% | -0.35 -218.18% | -0.06 82.86% | -0.13 -115.34% | 0.54 521.04% | 1.30 139.38% | 1.28 -2.09% | 2.44 91.60% | 3.11 27.35% | 3.71 19.34% | 6.50 75.00% | 7.17 10.36% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 96.23% | 0.03 190.68% | 0.14 214.75% | 0.18 512.00% | 0.27 8,007.81% | 0.27 874.88% | 0.30 114.81% | 0.34 83.33% | 0.38 40.51% |
| Revenue Q2Q % growth | 10.741M 46.88% | 13.767M 72.82% | 18.384M 102.60% | 22.222M 115.25% | 27.192M 153.16% | 23.052M 67.44% | 24.888M 35.38% | 26.418M 18.88% | 27.744M 2.03% |
| EBITDA Q2Q % growth | 959.82K 187.90% | 2.077M 479.01% | 3.87M 259.79% | 6.762M 420.15% | 8.687M 805.07% | 8.177M 293.69% | 9.234M 138.60% | 10.144M 50.01% | 11.389M 31.10% |
| EBIT Q2Q % growth | 58.477K 102.93% | 855.27K 206.91% | 3.468M 218.16% | 4.333M 751.28% | 6.724M 11,398.62% | 7.854M 818.31% | 8.976M 158.82% | 9.894M 128.34% | 11.118M 65.35% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.03 250.00% | -0.01 | 0.04 | 394.12% |
| Q2 2024 Q2Q % growth | -0.12 -180.00% | -0.07 | -0.05 | -68.07% |
| Q1 2024 Q2Q % growth | -0.03 70.00% | -0.05 | 0.02 | 34.64% |
| Q4 2023 Q2Q % growth | -0.09 -325.00% | -0.04 | -0.05 | -120.59% |
| Q3 2023 Q2Q % growth | -0.02 83.33% | -0.10 | 0.08 | 80.39% |
| Q2 2023 Q2Q % growth | 0.15 350.00% | -0.09 | 0.24 | 263.40% |
| Q1 2023 Q2Q % growth | -0.10 52.38% | -0.14 | 0.04 | 29.97% |
| Q4 2022 Q2Q % growth | 0.04 | 0.01 | 0.03 | 292.16% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.15 | 0.03 | 21.57% |
| Q2 2022 Q2Q % growth | -0.06 40.00% | 0.03 | -0.09 | -296.08% |
| Q1 2022 Q2Q % growth | -0.21 -210.53% | -0.08 | -0.13 | -157.35% |
| Q4 2021 Q2Q % growth | 0.04 112.50% | 0.19 | -0.15 | -79.36% |
| Q3 2021 Q2Q % growth | -0.24 22.58% | -0.14 | -0.10 | -74.29% |
| Q2 2021 Q2Q % growth | -0.10 56.52% | -0.14 | 0.04 | 29.97% |
| Q1 2021 Q2Q % growth | 0.19 138.00% | 0.19 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | -0.32 -113.33% | -0.27 | -0.05 | -20.66% |
| Q3 2020 Q2Q % growth | -0.31 -10.71% | -0.26 | -0.05 | -19.97% |
| Q2 2020 Q2Q % growth | -0.23 -27.78% | -0.27 | 0.04 | 13.27% |
| Q1 2020 Q2Q % growth | -0.50 | -0.23 | -0.27 | -119.49% |
| Q4 2019 Q2Q % growth | -0.15 | -0.27 | 0.12 | 44.15% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -11.29% |
| Q2 2019 Q2Q % growth | -0.18 | -0.28 | 0.10 | 35.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.324M 46.90% | 9.889M | 435K | 4.40% |
| Q2 2024 Q2Q % growth | 9.074M -24.36% | 8.976M | 98K | 1.09% |
| Q1 2024 Q2Q % growth | 7.966M 50.19% | 8.16M | -194K | -2.38% |
| Q4 2023 Q2Q % growth | 7.313M -13.96% | 7.854M | -541K | -6.89% |
| Q3 2023 Q2Q % growth | 7.028M 118.26% | 6.384M | 644K | 10.09% |
| Q2 2023 Q2Q % growth | 11.997M 63.00% | 6.639M | 5.358M | 80.70% |
| Q1 2023 Q2Q % growth | 5.304M 143.30% | 4.647M | 657K | 14.14% |
| Q4 2022 Q2Q % growth | 8.5M 39.57% | 9.301M | -801K | -8.61% |
| Q3 2022 Q2Q % growth | 3.22M 312.82% | 3.11M | 110K | 3.54% |
| Q2 2022 Q2Q % growth | 7.36M 139.74% | 7.92M | -560K | -7.07% |
| Q1 2022 Q2Q % growth | 2.18M -81.68% | 7.242M | -5.062M | -69.90% |
| Q4 2021 Q2Q % growth | 6.09M 7,512.50% | 12.768M | -6.678M | -52.30% |
| Q3 2021 Q2Q % growth | 780K 587.50% | 3.102M | -2.322M | -74.85% |
| Q2 2021 Q2Q % growth | 3.07M 15,250.00% | 3.887M | -817K | -21.02% |
| Q1 2021 Q2Q % growth | 11.9M 11,800.00% | 12.295M | -395K | -3.21% |
| Q4 2020 Q2Q % growth | 80K -82.61% | 1.361M | -1.281M | -94.12% |
| Q3 2020 Q2Q % growth | -160K | 1.519M | -1.679M | -110.53% |
| Q2 2020 Q2Q % growth | 20K | 300.217K | -280.217K | -93.34% |
| Q1 2020 Q2Q % growth | 100K -80.00% | 1.545M | -1.445M | -93.53% |
| Q4 2019 Q2Q % growth | 460K | 683.737K | -223.737K | -32.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -200% | 0% | 10% |
| Revenue | 0% | -3.23% | 0.02% | 2.22% |